The release of cisplatin from mesoporous materials
碩士 === 國立臺灣海洋大學 === 生物科技研究所 === 95 === There is an increasing interest in optimizing the efficacy of drug activity by using rationally designed and prepared drug carrier materials, and many efforts have recently been devoted to design and prepare sustained and controlled drug-release systems. Amorph...
Main Authors: | , |
---|---|
Other Authors: | |
Format: | Others |
Language: | zh-TW |
Published: |
2007
|
Online Access: | http://ndltd.ncl.edu.tw/handle/84375349332064000825 |
id |
ndltd-TW-095NTOU5111008 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-TW-095NTOU51110082015-10-13T11:31:39Z http://ndltd.ncl.edu.tw/handle/84375349332064000825 The release of cisplatin from mesoporous materials 中孔洞材料的cisplatin藥物釋放 Wei-Chun Chen 陳韋均 碩士 國立臺灣海洋大學 生物科技研究所 95 There is an increasing interest in optimizing the efficacy of drug activity by using rationally designed and prepared drug carrier materials, and many efforts have recently been devoted to design and prepare sustained and controlled drug-release systems. Amorphous colloidal and porous silica are used as adjuvants in pharmaceutical technology. The advantages of using silica species as a drug carrier system are their nontoxic nature, high stability, and good biocompatibility. Mesoporous silica materials, MCM-41 and SBA-15 have attracted much attention, owing to their novel properties, such as large surface area, highly regular and unique tunable nanometer pore sizes, and tailorable surface chemical properties, which qualify them as very promising candidates for multifunctional drug carriers. Cisplatin, a drug which could suppress cell histiocytosis, is also a kind of antineoplastic agent. We use MCM-41 or SBA as drug carrier for cisplatin .In Stimulated stomach pH 1.2 solution, We confirmed that cisplatin in mesoporous materials would pass stomach entirely . Moreover, MBT-2 cell uptake cisplatin by endocytosis pathway, and the uptake maximum appear in 5 hours. Hsiu-Mei Lin 林秀美 2007 學位論文 ; thesis 87 zh-TW |
collection |
NDLTD |
language |
zh-TW |
format |
Others
|
sources |
NDLTD |
description |
碩士 === 國立臺灣海洋大學 === 生物科技研究所 === 95 === There is an increasing interest in optimizing the efficacy of drug activity by using rationally designed and prepared drug carrier materials, and many efforts have recently been devoted to design and prepare sustained and controlled drug-release systems. Amorphous colloidal and porous silica are used as adjuvants in pharmaceutical technology. The advantages of using silica species as a drug carrier system are their nontoxic nature, high stability, and good biocompatibility. Mesoporous silica materials, MCM-41 and SBA-15 have attracted much attention, owing to their novel properties, such as large surface area, highly regular and unique tunable nanometer pore sizes, and tailorable surface chemical properties, which qualify them as very promising candidates for multifunctional drug carriers. Cisplatin, a drug which could suppress cell histiocytosis, is also a kind of antineoplastic agent. We use MCM-41 or SBA as drug carrier for cisplatin .In Stimulated stomach pH 1.2 solution, We confirmed that cisplatin in mesoporous materials would pass stomach entirely . Moreover, MBT-2 cell uptake cisplatin by endocytosis pathway, and the uptake maximum appear in 5 hours.
|
author2 |
Hsiu-Mei Lin |
author_facet |
Hsiu-Mei Lin Wei-Chun Chen 陳韋均 |
author |
Wei-Chun Chen 陳韋均 |
spellingShingle |
Wei-Chun Chen 陳韋均 The release of cisplatin from mesoporous materials |
author_sort |
Wei-Chun Chen |
title |
The release of cisplatin from mesoporous materials |
title_short |
The release of cisplatin from mesoporous materials |
title_full |
The release of cisplatin from mesoporous materials |
title_fullStr |
The release of cisplatin from mesoporous materials |
title_full_unstemmed |
The release of cisplatin from mesoporous materials |
title_sort |
release of cisplatin from mesoporous materials |
publishDate |
2007 |
url |
http://ndltd.ncl.edu.tw/handle/84375349332064000825 |
work_keys_str_mv |
AT weichunchen thereleaseofcisplatinfrommesoporousmaterials AT chénwéijūn thereleaseofcisplatinfrommesoporousmaterials AT weichunchen zhōngkǒngdòngcáiliàodecisplatinyàowùshìfàng AT chénwéijūn zhōngkǒngdòngcáiliàodecisplatinyàowùshìfàng AT weichunchen releaseofcisplatinfrommesoporousmaterials AT chénwéijūn releaseofcisplatinfrommesoporousmaterials |
_version_ |
1716845387912839168 |